Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
Open Access
- 19 October 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (40) , 42632-42650
Abstract
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancerKeywords
This publication has 45 references indexed in Scilit:
- Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast CancerPLOS ONE, 2013
- The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic TargetPLOS ONE, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4Journal of Lipid Research, 2011
- Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer CellsPLOS ONE, 2010
- Rictor Phosphorylation on the Thr-1135 Site Does Not Require Mammalian Target of Rapamycin Complex 2Molecular Cancer Research, 2010
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapyOncogene, 2010
- Molecular mechanisms of mTOR-mediated translational controlNature Reviews Molecular Cell Biology, 2009
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005